Rapid bilateral visual loss as the initial clinical manifestation in idiopathic hypertrophic cranial pachymeningitis

• Published in: Clinical case reports Vol. 10; no. 5; pp. e05825 - n/a
• Main Authors: Shao, Weiyang, Tian, Chunyu, Gao, Lixiong, Cui, Bei, Shi, Qian
• Format: Journal Article
• Language: English
• Published: England John Wiley & Sons, Inc 01.05.2022; John Wiley and Sons Inc; Wiley
• Subjects: Antibodies; Biochemistry; Blood; Brain research; Cardiovascular disease; Case Report; Case Reports; Consent; dural thickening; Ethics; Headaches; idiopathic hypertrophic cranial pachymeningitis; Inflammatory diseases; Laboratories; Magnetic resonance imaging; Optic nerve; optic nerve injury; Optics; Patients; Photography; Tomography; Tuberculosis; visual loss; optic nerve injury; idiopathic hypertrophic cranial pachymeningitis; dural thickening; visual loss
• ISSN: 2050-0904; 2050-0904
• DOI: 10.1002/ccr3.5825

A 59‐year‐old patient presented with 4‐day acute painless bilateral visual loss, MRI results showed dura enhancement of the frontal, anterior cranial fossa. The patient was considered to have idiopathic hypertrophic cranial pachymeningitis based on laboratory tests and MRI data. After treatment with hormones, the visual acuity obviously improved. We reported a patient presented with 4‐day acute painless bilateral visual loss, who was diagnosed to have idiopathic hypertrophic cranial pachymeningitis based on laboratory tests and MRI data, the visual acuity obviously improved after timely treatment. Therefore, Intracranial changes should be considered in patients with a sharp decline in visual acuity but with no obviously positive signs of the eye fundus.